The perception of ketamine has shifted dramatically. Once associated primarily with street drug use, it’s increasingly appearing in clinical and mainstream wellness contexts, prompting questions about its actual profile and potential. The DEA describes ketamine as a “dissociative anesthetic that has some hallucinogenic effects.” In the 70s, it was marketed as a short-acting anesthetic safe for use on both humans and animals, but was officially classified as a Schedule III non-narcotic in 1999.
How Ketamine Works
High doses of ketamine cause sedation; lower doses produce psychoactive effects. Common experiences include “K-land,” a desired euphoric state, and heavier use can lead to a “K-hole,” an out-of-body, intensely hallucinogenic and often paralyzing state. The variation in experience depends on dosage and what the drug is mixed with.
Ketamine hasn’t reached cocaine-level danger largely due to its “wide therapeutic range”—there’s a significant difference between the lethal dose and the dose that produces a high. Additionally, it’s more psychologically addictive than physically addictive. Studies show dependence is driven by craving and developed tolerance rather than physical withdrawal symptoms. Ketamine trips are shorter than those from other hallucinogens like LSD and PCP, typically lasting 30 to 60 minutes.
Medical Applications and Fast-Acting Benefits
Ketamine affects multiple brain systems by blocking NMDA receptors and suppressing communication between synapses. While blocking NMDA receptors in one area, it heightens activity in others. For people with depression, ketamine-induced neural activity can create new neural pathways and increase neural plasticity, making it a promising treatment. Unlike traditional antidepressants that take days to work, ketamine acts quickly—positive changes can be noticed within an hour of dosage.
A 2019 study showed that slow IV ketamine given to patients with severe depression and anxiety significantly decreased symptom severity. In January 2025, the FDA approved a ketamine nasal spray, esketamine, for treatment-resistant depression. Jennifer Affleck from “Secret Lives of Mormon Wives” credits ketamine therapy with helping her marriage, saying it enabled her and her husband to “actually relive those experiences, not just recall them.”
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://utdailybeacon.com/210521/opinion/opinion-when-did-ketamine-get-cool/